Hiroshi Gomyo Selected Research

Hiroshi Gomyo Research Topics

Disease

5	Lymphoma (Lymphomas) 09/2018 - 10/2003
3	Neoplasms (Cancer) 12/2011 - 10/2003
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2021 - 12/2003
2	T-Cell Lymphoma (Lymphoma, T Cell) 12/2017 - 12/2011
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2007 - 12/2003
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2005 - 10/2003
1	Multiple Myeloma 07/2021
1	Hepatitis 05/2021
1	Asthma (Bronchial Asthma) 01/2019
1	Systemic Mastocytosis 01/2019
1	Ascites 01/2019
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 09/2018
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2018
1	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2018
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 12/2017
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2017
1	Anorexia 12/2016
1	Vomiting 12/2016
1	Nausea 12/2016
1	Acute Promyelocytic Leukemia 11/2014
1	Extranodal NK-T-Cell Lymphoma 12/2011
1	Paraproteinemias (Monoclonal Gammopathy) 08/2007
1	Chromosome Aberrations (Chromosome Abnormalities) 08/2007
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 08/2007
1	Philadelphia Chromosome 10/2005
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2003
1	Pericardial Effusion 10/2003
1	Atrioventricular Block 10/2003
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2003
1	Invasive Pulmonary Aspergillosis 10/2003
1	Aspergillosis 10/2003
1	Rheumatoid Arthritis 10/2003
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 10/2003
1	Pericarditis 10/2003

Drug/Important Bio-Agent (IBA)

3	Rituximab (Mabthera)FDA Link 05/2021 - 08/2007
2	DNA (Deoxyribonucleic Acid)IBA 05/2021 - 12/2011
2	Cladribine FDA LinkGeneric 01/2019 - 08/2007
1	IntegrinsIBA 07/2021
1	Surface Antigens (Surface Antigen)IBA 05/2021
1	Alanine Transaminase (SGPT)IBA 05/2021
1	lipoarabinomannan (LAM)IBA 05/2021
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 05/2021
1	Antiviral Agents (Antivirals)IBA 05/2021
1	Dasatinib (BMS 354825)FDA Link 01/2019
1	Tryptases (Tryptase)IBA 01/2019
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2019
1	pranlukastIBA 01/2019
1	InterferonsIBA 01/2019
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 09/2018
1	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2018
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 07/2018
1	Imatinib Mesylate (Gleevec)FDA Link 02/2018
1	Prednisone (Sone)FDA LinkGeneric 12/2017
1	Anaplastic Lymphoma KinaseIBA 12/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2017
1	Etoposide (VP 16)FDA LinkGeneric 12/2017
1	Vincristine (Oncovin)FDA LinkGeneric 12/2017
1	SteroidsIBA 12/2016
1	AntiemeticsIBA 12/2016
1	Palonosetron (Aloxi)FDA Link 12/2016
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2014
1	tamibaroteneIBA 11/2014
1	Indicators and Reagents (Reagents)IBA 12/2011
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 06/2010
1	Immunoglobulin M (IgM)IBA 08/2007
1	T-18 (T 18)IBA 12/2003
1	Methotrexate (Mexate)FDA LinkGeneric 10/2003

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 05/2021 - 10/2003
6	Therapeutics 05/2021 - 10/2003
2	Induction Chemotherapy 05/2021 - 10/2003
1	Punctures 01/2019
1	Stem Cell Transplantation 09/2018
1	VAP-cyclo protocol 12/2016
1	Intravenous Injections 12/2016
1	Combination Drug Therapy (Combination Chemotherapy) 10/2003
1	Aftercare (After-Treatment) 10/2003